Shares of DXCM Up 26.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 23, 11:40AM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ
DXCM: 54.94 (+0.99)
3 Healthcare Technologies That Are Set to Transform Our Lives Over the Next 10-20 Years
Motley Fool Staff - Motley Fool - Sat Dec 20, 5:45PM CST
Source: Touch Bionics. Cutting-edge technology could reshape healthcare over the coming 10-20 years, in the process curbing runaway spending and improving the lives of millions of patients. Which technologies might move the needle most? Three...
DXCM: 54.94 (+0.99), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), WAG: 76.67 (+0.16)
Insider Trading Alert - DXCM, ALXN And FRGI Traded By Insiders
at The Street - Wed Dec 17, 12:45PM CST
Stocks with insider trader activity include DXCM, ALXN and FRGI
DXCM: 54.94 (+0.99), ALXN: 181.96 (+3.09), FRGI: 56.97 (+0.47)
22.5% Return Seen to Date on SmarTrend DexCom Call (DXCM)
Comtex SmarTrend(R) - Tue Dec 16, 9:46AM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ
DXCM: 54.94 (+0.99)
DexCom Shares Up 28.8% Since SmarTrend's Buy Recommendation (DXCM)
Comtex SmarTrend(R) - Tue Dec 09, 9:11AM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ
DXCM: 54.94 (+0.99)
Update: FDA Clears Johnson & Johnson's Insulin Pump, An Artificial Pancreas Quickened
Andy Batts - at Seeking Alpha - Fri Dec 05, 12:31PM CST
JNJ: 104.59 (+0.31), DXCM: 54.94 (+0.99)
DexCom CEO Terry Gregg Explains 50% YTD Stock Leap, Plans for 2015
at The Street - Wed Dec 03, 3:54PM CST
DexCom shares are up over 50% for the year on four FDA approvals. CEO Terry Gregg says technology is driving its products to the forefront.
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), PODD: 46.24 (+0.90), DXCM: 54.94 (+0.99), TNDM: 12.98 (-0.02), AAPL: 112.01 (-0.53)
DexCom to Present at Oppenheimer 25th Annual Healthcare Conference
Business Wire - Wed Dec 03, 7:30AM CST
DexCom, Inc. (NASDAQ
DXCM: 54.94 (+0.99)
18.4% Return Seen to Date on SmarTrend DexCom Call (DXCM)
Comtex SmarTrend(R) - Mon Dec 01, 4:51PM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ
DXCM: 54.94 (+0.99)
DexCom to Present at 26th Annual Piper Jaffray Healthcare Conference
Business Wire - Tue Nov 25, 7:30AM CST
DexCom, Inc. (NASDAQ
DXCM: 54.94 (+0.99)
DexCom Up 16.2% Since SmarTrend Uptrend Call (DXCM)
Comtex SmarTrend(R) - Mon Nov 24, 11:18AM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ
DXCM: 54.94 (+0.99)
Post Earnings Update: DexCom Has Climbed 12.9% Higher in Past 2 Weeks (DXCM)
Comtex SmarTrend(R) - Mon Nov 24, 9:05AM CST
When DexCom (NASDAQ
DXCM: 54.94 (+0.99)
DexCom names Mark G. Foletta to board
M2 - Thu Nov 20, 5:38AM CST
Ambulatory glucose monitoring company DexCom (NasdaqGS
DXCM: 54.94 (+0.99), RGLS: 14.78 (+0.24)
DexCom Announces Appointment of Mark G. Foletta as Board Member
Business Wire - Wed Nov 19, 7:30AM CST
DexCom, Inc. (NASDAQ
DXCM: 54.94 (+0.99), RGLS: 14.78 (+0.24)
Update: DexCom Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Tue Nov 18, 8:08AM CST
DXCM: 54.94 (+0.99)
Post Earnings Update: DexCom Has Climbed 18.1% Higher in Past Week (DXCM)
Comtex SmarTrend(R) - Mon Nov 17, 1:28PM CST
When DexCom (NASDAQ
DXCM: 54.94 (+0.99)
DexCom Up 21.6% Since SmarTrend Uptrend Call (DXCM)
Comtex SmarTrend(R) - Mon Nov 17, 10:26AM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ
DXCM: 54.94 (+0.99)
DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - Mon Nov 17, 10:15AM CST
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), DXCM: 54.94 (+0.99), MDT: 74.08 (+0.31)
DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 45.70 (-0.02), JNJ: 104.59 (+0.31), DXCM: 54.94 (+0.99), MDT: 74.08 (+0.31)
DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:54PM CST
Following the announcement, shares of DexCom, Inc. (DXCM) shot up nearly 14.12% to close at $50.93 in the last trading session.
ABT: 45.70 (-0.02), JNJ: 104.59 (+0.31), DXCM: 54.94 (+0.99), MDT: 74.08 (+0.31)